These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 37490236)

  • 21. Application of COL1A1-PDGFB fusion gene detection by fluorescence in situ hybridization in biopsy tissue of dermatofibrosarcoma protuberans.
    Zhang Z; Chen H; Chen M; He X; Wang Y; Zhang H
    J Dermatol; 2017 Jul; 44(7):798-802. PubMed ID: 28150334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans.
    Eilers G; Czaplinski JT; Mayeda M; Bahri N; Tao D; Zhu M; Hornick JL; Lindeman NI; Sicinska E; Wagner AJ; Fletcher JA; Mariño-Enriquez A
    Mol Cancer Ther; 2015 Jun; 14(6):1346-53. PubMed ID: 25852058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Programmed death-ligand 1 expression is associated with fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
    Tsuchihashi K; Kusaba H; Yamada Y; Okumura Y; Shimokawa H; Komoda M; Uchino K; Yoshihiro T; Tsuruta N; Hanamura F; Inadomi K; Ito M; Sagara K; Nakano M; Nio K; Arita S; Ariyama H; Kohashi K; Tominaga R; Oda Y; Akashi K; Baba E
    Mol Clin Oncol; 2017 May; 6(5):665-668. PubMed ID: 28515919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrosarcomatous pigmented dermatofibrosarcoma protuberans: A case report with review of the literature.
    Ishida M; Okabe H
    Oncol Lett; 2012 Sep; 4(3):390-392. PubMed ID: 23741240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dermatofibrosarcoma protuberans with platelet-derived growth factor-D rearrangement; two cases with morphologically distinct presentations.
    Campbell K; Bridge JA; DiMaio D; Wilson J; Shalin SC; Gardner JM
    J Cutan Pathol; 2022 Mar; 49(3):274-277. PubMed ID: 34628665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant: 10 years' experience in a tertiary hospital.
    Lo CH; Tsang PM; Cheng SY
    Autops Case Rep; 2022; 12():e2021368. PubMed ID: 35496732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans.
    Kiuru-Kuhlefelt S; El-Rifai W; Fanburg-Smith J; Kere J; Miettinen M; Knuutila S
    Cytogenet Cell Genet; 2001; 92(3-4):192-5. PubMed ID: 11435686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications.
    Ha SY; Lee SE; Kwon MJ; Kim YJ; Lee EH; Seo J; Jang KT; Lee J; Choi YL
    Hum Pathol; 2013 Jul; 44(7):1300-9. PubMed ID: 23347652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrosarcomatous Transformation in Dermatofibrosarcoma Protuberans of the Male Breast and its Association with Magnetic Resonance Imaging and Immunohistopathologic Features.
    Kang SY; Choi EJ; Jang KY
    Curr Med Imaging; 2024; 20():e15734056309290. PubMed ID: 38757329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.
    McArthur GA; Demetri GD; van Oosterom A; Heinrich MC; Debiec-Rychter M; Corless CL; Nikolova Z; Dimitrijevic S; Fletcher JA
    J Clin Oncol; 2005 Feb; 23(4):866-73. PubMed ID: 15681532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dermatofibrosarcoma Protuberans: An Updated Review of the Literature.
    Jozwik M; Bednarczuk K; Osierda Z
    Cancers (Basel); 2024 Sep; 16(18):. PubMed ID: 39335097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
    Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D
    Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrosarcomatous dermatofibrosarcoma protuberans from scar following trauma.
    Lee SW; Zaesim A; Jackson A; Borkat M
    Autops Case Rep; 2018; 8(4):e2018039. PubMed ID: 30775318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management.
    Llombart B; Serra-Guillén C; Monteagudo C; López Guerrero JA; Sanmartín O
    Semin Diagn Pathol; 2013 Feb; 30(1):13-28. PubMed ID: 23327727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel MAP3K7CL-ERG fusion in a molecularly confirmed case of dermatofibrosarcoma protuberans with fibrosarcomatous transformation.
    Maloney N; Bridge JA; de Abreu F; Korkolopoulou P; Sakellariou S; Linos K
    J Cutan Pathol; 2019 Jul; 46(7):532-537. PubMed ID: 30950098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary metastases of fibrosarcomatous dermatofibrosarcoma protuberans respond to apatinib-based angiogenesis and chemotherapy: a case report.
    Chen H; Liu Y; Peng F; Huang J; Wen X; Ding Z; Zhang S; Zhang Y; Lu Y
    Ann Transl Med; 2019 Apr; 7(7):149. PubMed ID: 31157270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Target therapy of unresectable or metastatic dermatofibrosarcoma protuberans with imatinib mesylate: an analysis on 22 Chinese patients.
    Wang C; Luo Z; Chen J; Zheng B; Zhang R; Chen Y; Shi Y
    Medicine (Baltimore); 2015 May; 94(17):e773. PubMed ID: 25929918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alteration of PDGFRβ-Akt-mTOR pathway signaling in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
    Hiraki-Hotokebuchi Y; Yamada Y; Kohashi K; Yamamoto H; Endo M; Setsu N; Yuki K; Ito T; Iwamoto Y; Furue M; Oda Y
    Hum Pathol; 2017 Sep; 67():60-68. PubMed ID: 28711648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Characterization of Dermatofibrosarcoma Protuberans: The Clinicopathologic Significance of Uncommon Fusion Gene Rearrangements and Their Diagnostic Importance in the Exclusively Subcutaneous and Circumscribed Lesions.
    Lee PH; Huang SC; Wu PS; Tai HC; Lee CH; Lee JC; Kao YC; Tsai JW; Hsieh TH; Li CF; Li WS; Liu TT; Su YL; Yu SC; Huang HY
    Am J Surg Pathol; 2022 Jul; 46(7):942-955. PubMed ID: 35034038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biphasic dermatofibrosarcoma protuberans with a labyrinthine plexiform high-grade fibrosarcomatous transformation.
    Monteagudo C; Llombart B; Burgués O; Rubio L; Calabuig S; Sanmartín O; López-Guerrero JA
    J Cutan Pathol; 2015 Mar; 42(3):206-212. PubMed ID: 25410704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.